Loading…

Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma

Background. Increased preoperative serum squamous cell carcinoma antigen (SCC-Ag) concentrations have been found to be associated with advanced stage and poor prognosis in lung and cervical cancers. Because little was known about the significance of SCC-Ag concentration in patients with esophageal c...

Full description

Saved in:
Bibliographic Details
Published in:Surgery 2003-05, Vol.133 (5), p.486-494
Main Authors: Shimada, Hideaki, Nabeya, Yoshihiro, Okazumi, Shin-ichi, Matsubara, Hisahiro, Shiratori, Tooru, Gunji, Yoshio, Kobayashi, Susumu, Hayashi, Hideki, Ochiai, Takenori
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c364t-9aab72743931042228c08cbdb8dc3ea0742334c98dc46c55268d10ab18277c663
cites cdi_FETCH-LOGICAL-c364t-9aab72743931042228c08cbdb8dc3ea0742334c98dc46c55268d10ab18277c663
container_end_page 494
container_issue 5
container_start_page 486
container_title Surgery
container_volume 133
creator Shimada, Hideaki
Nabeya, Yoshihiro
Okazumi, Shin-ichi
Matsubara, Hisahiro
Shiratori, Tooru
Gunji, Yoshio
Kobayashi, Susumu
Hayashi, Hideki
Ochiai, Takenori
description Background. Increased preoperative serum squamous cell carcinoma antigen (SCC-Ag) concentrations have been found to be associated with advanced stage and poor prognosis in lung and cervical cancers. Because little was known about the significance of SCC-Ag concentration in patients with esophageal cancer, the aim of this study was to analyze the clinicopathologic significance of SCC-Ag in patients with esophageal SCC. Patients and Methods. Preoperative SCC-Ag concentration was measured with enzyme-linked immunosorbent assay in 309 patients with primary esophageal SCC. All patients underwent curative radical surgery without any preoperative therapy. In 215 of 309 patients, carcinoembryonic antigen (CEA) was also measured to compare clinical significance of CEA with that of SCC-Ag. The prognostic significance for survival of SCC-Ag concentrations was studied with multivariate analysis with Cox proportional hazards model. Results. The SCC-Ag concentration and the positivity rate of SCC-Ag were significantly elevated in patients associated with tumor progression. Statistically significant differences in SCC-Ag concentrations and SCC-Ag positivity rates were observed depending on tumor size, tumor depth, lymph node status, and distant metastasis. Although CEA was not a prognostic factor (P =.21), a high SCC-Ag concentration was a significant prognostic factor (P
doi_str_mv 10.1067/msy.2003.139
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73331346</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039606003000436</els_id><sourcerecordid>73331346</sourcerecordid><originalsourceid>FETCH-LOGICAL-c364t-9aab72743931042228c08cbdb8dc3ea0742334c98dc46c55268d10ab18277c663</originalsourceid><addsrcrecordid>eNp1kU1vEzEQhi0Eomngxhn5Aqdu8Ffs3SOq-JIqwQHO1uzspDXaj9Szm6r8ehwlUi9wsmb0-NXrx0K80WqjlQ8fBn7cGKXsRtvmmVjprTVVsF4_F6uybSqvvLoQl8y_lVKN0_VLcaFNCLYJfiX-_MjUJZzTNMppJ3nJh3SAXj6k-U7y_QLDtLBE6nuJkDGN0wASxjnd0ijTKPcwJxpnPl3IxIQztD1J4ml_B7dUsv4T80q82EHP9Pp8rsWvz59-Xn-tbr5_-Xb98aZC691cNQBtMMHZxmrljDE1qhrbrq07tAQqOGOtw6aMzuN2a3zdaQWtrssj0Xu7Fu9Pufs83S_EcxwSH6vASKVVDNZabd0RvDqBmCfmTLu4z2mA_Bi1ikfXsbiOR9exuC7423Pu0g7UPcFnuQV4dwaAEfpdhhETP3GuDt6X9mvhTxwVC4dEOTIWqVg-JhedsZvSvxv8BeQvm-Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73331346</pqid></control><display><type>article</type><title>Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma</title><source>ScienceDirect Journals</source><creator>Shimada, Hideaki ; Nabeya, Yoshihiro ; Okazumi, Shin-ichi ; Matsubara, Hisahiro ; Shiratori, Tooru ; Gunji, Yoshio ; Kobayashi, Susumu ; Hayashi, Hideki ; Ochiai, Takenori</creator><creatorcontrib>Shimada, Hideaki ; Nabeya, Yoshihiro ; Okazumi, Shin-ichi ; Matsubara, Hisahiro ; Shiratori, Tooru ; Gunji, Yoshio ; Kobayashi, Susumu ; Hayashi, Hideki ; Ochiai, Takenori</creatorcontrib><description>Background. Increased preoperative serum squamous cell carcinoma antigen (SCC-Ag) concentrations have been found to be associated with advanced stage and poor prognosis in lung and cervical cancers. Because little was known about the significance of SCC-Ag concentration in patients with esophageal cancer, the aim of this study was to analyze the clinicopathologic significance of SCC-Ag in patients with esophageal SCC. Patients and Methods. Preoperative SCC-Ag concentration was measured with enzyme-linked immunosorbent assay in 309 patients with primary esophageal SCC. All patients underwent curative radical surgery without any preoperative therapy. In 215 of 309 patients, carcinoembryonic antigen (CEA) was also measured to compare clinical significance of CEA with that of SCC-Ag. The prognostic significance for survival of SCC-Ag concentrations was studied with multivariate analysis with Cox proportional hazards model. Results. The SCC-Ag concentration and the positivity rate of SCC-Ag were significantly elevated in patients associated with tumor progression. Statistically significant differences in SCC-Ag concentrations and SCC-Ag positivity rates were observed depending on tumor size, tumor depth, lymph node status, and distant metastasis. Although CEA was not a prognostic factor (P =.21), a high SCC-Ag concentration was a significant prognostic factor (P &lt;.01). Multivariate analyses indicated that T factor had the best predictive power, but SCC-Ag concentration contained additional, independent prognostic information. Conclusion. Our findings suggest that preoperative serum SCC-Ag concentrations might provide a predictive information for tumor progression and survival in patients with esophageal SCC. (Surgery 2003;133:486-94.)</description><identifier>ISSN: 0039-6060</identifier><identifier>EISSN: 1532-7361</identifier><identifier>DOI: 10.1067/msy.2003.139</identifier><identifier>PMID: 12773976</identifier><identifier>CODEN: SURGAZ</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antigens, Neoplasm - analysis ; Biological and medical sciences ; Carcinoembryonic Antigen - analysis ; Carcinoma, Squamous Cell - immunology ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - surgery ; Disease Progression ; Esophageal Neoplasms - immunology ; Esophageal Neoplasms - pathology ; Esophageal Neoplasms - surgery ; Esophagectomy ; Esophagus ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Lymph Node Excision ; Male ; Medical sciences ; Middle Aged ; Neoplasm Staging ; Osmolar Concentration ; Postoperative Period ; Prognosis ; Serpins ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the digestive system ; Survival Analysis ; Tumors</subject><ispartof>Surgery, 2003-05, Vol.133 (5), p.486-494</ispartof><rights>2003 Mosby, Inc.</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c364t-9aab72743931042228c08cbdb8dc3ea0742334c98dc46c55268d10ab18277c663</citedby><cites>FETCH-LOGICAL-c364t-9aab72743931042228c08cbdb8dc3ea0742334c98dc46c55268d10ab18277c663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14876642$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12773976$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shimada, Hideaki</creatorcontrib><creatorcontrib>Nabeya, Yoshihiro</creatorcontrib><creatorcontrib>Okazumi, Shin-ichi</creatorcontrib><creatorcontrib>Matsubara, Hisahiro</creatorcontrib><creatorcontrib>Shiratori, Tooru</creatorcontrib><creatorcontrib>Gunji, Yoshio</creatorcontrib><creatorcontrib>Kobayashi, Susumu</creatorcontrib><creatorcontrib>Hayashi, Hideki</creatorcontrib><creatorcontrib>Ochiai, Takenori</creatorcontrib><title>Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma</title><title>Surgery</title><addtitle>Surgery</addtitle><description>Background. Increased preoperative serum squamous cell carcinoma antigen (SCC-Ag) concentrations have been found to be associated with advanced stage and poor prognosis in lung and cervical cancers. Because little was known about the significance of SCC-Ag concentration in patients with esophageal cancer, the aim of this study was to analyze the clinicopathologic significance of SCC-Ag in patients with esophageal SCC. Patients and Methods. Preoperative SCC-Ag concentration was measured with enzyme-linked immunosorbent assay in 309 patients with primary esophageal SCC. All patients underwent curative radical surgery without any preoperative therapy. In 215 of 309 patients, carcinoembryonic antigen (CEA) was also measured to compare clinical significance of CEA with that of SCC-Ag. The prognostic significance for survival of SCC-Ag concentrations was studied with multivariate analysis with Cox proportional hazards model. Results. The SCC-Ag concentration and the positivity rate of SCC-Ag were significantly elevated in patients associated with tumor progression. Statistically significant differences in SCC-Ag concentrations and SCC-Ag positivity rates were observed depending on tumor size, tumor depth, lymph node status, and distant metastasis. Although CEA was not a prognostic factor (P =.21), a high SCC-Ag concentration was a significant prognostic factor (P &lt;.01). Multivariate analyses indicated that T factor had the best predictive power, but SCC-Ag concentration contained additional, independent prognostic information. Conclusion. Our findings suggest that preoperative serum SCC-Ag concentrations might provide a predictive information for tumor progression and survival in patients with esophageal SCC. (Surgery 2003;133:486-94.)</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antigens, Neoplasm - analysis</subject><subject>Biological and medical sciences</subject><subject>Carcinoembryonic Antigen - analysis</subject><subject>Carcinoma, Squamous Cell - immunology</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Disease Progression</subject><subject>Esophageal Neoplasms - immunology</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Esophageal Neoplasms - surgery</subject><subject>Esophagectomy</subject><subject>Esophagus</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Lymph Node Excision</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Osmolar Concentration</subject><subject>Postoperative Period</subject><subject>Prognosis</subject><subject>Serpins</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the digestive system</subject><subject>Survival Analysis</subject><subject>Tumors</subject><issn>0039-6060</issn><issn>1532-7361</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNp1kU1vEzEQhi0Eomngxhn5Aqdu8Ffs3SOq-JIqwQHO1uzspDXaj9Szm6r8ehwlUi9wsmb0-NXrx0K80WqjlQ8fBn7cGKXsRtvmmVjprTVVsF4_F6uybSqvvLoQl8y_lVKN0_VLcaFNCLYJfiX-_MjUJZzTNMppJ3nJh3SAXj6k-U7y_QLDtLBE6nuJkDGN0wASxjnd0ijTKPcwJxpnPl3IxIQztD1J4ml_B7dUsv4T80q82EHP9Pp8rsWvz59-Xn-tbr5_-Xb98aZC691cNQBtMMHZxmrljDE1qhrbrq07tAQqOGOtw6aMzuN2a3zdaQWtrssj0Xu7Fu9Pufs83S_EcxwSH6vASKVVDNZabd0RvDqBmCfmTLu4z2mA_Bi1ikfXsbiOR9exuC7423Pu0g7UPcFnuQV4dwaAEfpdhhETP3GuDt6X9mvhTxwVC4dEOTIWqVg-JhedsZvSvxv8BeQvm-Q</recordid><startdate>20030501</startdate><enddate>20030501</enddate><creator>Shimada, Hideaki</creator><creator>Nabeya, Yoshihiro</creator><creator>Okazumi, Shin-ichi</creator><creator>Matsubara, Hisahiro</creator><creator>Shiratori, Tooru</creator><creator>Gunji, Yoshio</creator><creator>Kobayashi, Susumu</creator><creator>Hayashi, Hideki</creator><creator>Ochiai, Takenori</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030501</creationdate><title>Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma</title><author>Shimada, Hideaki ; Nabeya, Yoshihiro ; Okazumi, Shin-ichi ; Matsubara, Hisahiro ; Shiratori, Tooru ; Gunji, Yoshio ; Kobayashi, Susumu ; Hayashi, Hideki ; Ochiai, Takenori</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c364t-9aab72743931042228c08cbdb8dc3ea0742334c98dc46c55268d10ab18277c663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antigens, Neoplasm - analysis</topic><topic>Biological and medical sciences</topic><topic>Carcinoembryonic Antigen - analysis</topic><topic>Carcinoma, Squamous Cell - immunology</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Disease Progression</topic><topic>Esophageal Neoplasms - immunology</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Esophageal Neoplasms - surgery</topic><topic>Esophagectomy</topic><topic>Esophagus</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Lymph Node Excision</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Osmolar Concentration</topic><topic>Postoperative Period</topic><topic>Prognosis</topic><topic>Serpins</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the digestive system</topic><topic>Survival Analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimada, Hideaki</creatorcontrib><creatorcontrib>Nabeya, Yoshihiro</creatorcontrib><creatorcontrib>Okazumi, Shin-ichi</creatorcontrib><creatorcontrib>Matsubara, Hisahiro</creatorcontrib><creatorcontrib>Shiratori, Tooru</creatorcontrib><creatorcontrib>Gunji, Yoshio</creatorcontrib><creatorcontrib>Kobayashi, Susumu</creatorcontrib><creatorcontrib>Hayashi, Hideki</creatorcontrib><creatorcontrib>Ochiai, Takenori</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimada, Hideaki</au><au>Nabeya, Yoshihiro</au><au>Okazumi, Shin-ichi</au><au>Matsubara, Hisahiro</au><au>Shiratori, Tooru</au><au>Gunji, Yoshio</au><au>Kobayashi, Susumu</au><au>Hayashi, Hideki</au><au>Ochiai, Takenori</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma</atitle><jtitle>Surgery</jtitle><addtitle>Surgery</addtitle><date>2003-05-01</date><risdate>2003</risdate><volume>133</volume><issue>5</issue><spage>486</spage><epage>494</epage><pages>486-494</pages><issn>0039-6060</issn><eissn>1532-7361</eissn><coden>SURGAZ</coden><abstract>Background. Increased preoperative serum squamous cell carcinoma antigen (SCC-Ag) concentrations have been found to be associated with advanced stage and poor prognosis in lung and cervical cancers. Because little was known about the significance of SCC-Ag concentration in patients with esophageal cancer, the aim of this study was to analyze the clinicopathologic significance of SCC-Ag in patients with esophageal SCC. Patients and Methods. Preoperative SCC-Ag concentration was measured with enzyme-linked immunosorbent assay in 309 patients with primary esophageal SCC. All patients underwent curative radical surgery without any preoperative therapy. In 215 of 309 patients, carcinoembryonic antigen (CEA) was also measured to compare clinical significance of CEA with that of SCC-Ag. The prognostic significance for survival of SCC-Ag concentrations was studied with multivariate analysis with Cox proportional hazards model. Results. The SCC-Ag concentration and the positivity rate of SCC-Ag were significantly elevated in patients associated with tumor progression. Statistically significant differences in SCC-Ag concentrations and SCC-Ag positivity rates were observed depending on tumor size, tumor depth, lymph node status, and distant metastasis. Although CEA was not a prognostic factor (P =.21), a high SCC-Ag concentration was a significant prognostic factor (P &lt;.01). Multivariate analyses indicated that T factor had the best predictive power, but SCC-Ag concentration contained additional, independent prognostic information. Conclusion. Our findings suggest that preoperative serum SCC-Ag concentrations might provide a predictive information for tumor progression and survival in patients with esophageal SCC. (Surgery 2003;133:486-94.)</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>12773976</pmid><doi>10.1067/msy.2003.139</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0039-6060
ispartof Surgery, 2003-05, Vol.133 (5), p.486-494
issn 0039-6060
1532-7361
language eng
recordid cdi_proquest_miscellaneous_73331346
source ScienceDirect Journals
subjects Adult
Aged
Aged, 80 and over
Antigens, Neoplasm - analysis
Biological and medical sciences
Carcinoembryonic Antigen - analysis
Carcinoma, Squamous Cell - immunology
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - surgery
Disease Progression
Esophageal Neoplasms - immunology
Esophageal Neoplasms - pathology
Esophageal Neoplasms - surgery
Esophagectomy
Esophagus
Female
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Lymph Node Excision
Male
Medical sciences
Middle Aged
Neoplasm Staging
Osmolar Concentration
Postoperative Period
Prognosis
Serpins
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the digestive system
Survival Analysis
Tumors
title Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T20%3A20%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prediction%20of%20survival%20with%20squamous%20cell%20carcinoma%20antigen%20in%20patients%20with%20resectable%20esophageal%20squamous%20cell%20carcinoma&rft.jtitle=Surgery&rft.au=Shimada,%20Hideaki&rft.date=2003-05-01&rft.volume=133&rft.issue=5&rft.spage=486&rft.epage=494&rft.pages=486-494&rft.issn=0039-6060&rft.eissn=1532-7361&rft.coden=SURGAZ&rft_id=info:doi/10.1067/msy.2003.139&rft_dat=%3Cproquest_cross%3E73331346%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c364t-9aab72743931042228c08cbdb8dc3ea0742334c98dc46c55268d10ab18277c663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73331346&rft_id=info:pmid/12773976&rfr_iscdi=true